CN Patent
CN115974799B — 氨基甲酸酯取代的醇衍生物及其在医药上的应用
Assigned to Kangbaida Sichuan Biopharmaceutical Technology Co ltd · Expires 2024-08-13 · 2y expired
What this patent protects
本发明涉及一种氨基甲酸酯取代的醇衍生物、其立体异构体或者药学上可接受的盐,及其在医药上的应用。
USPTO Abstract
本发明涉及一种氨基甲酸酯取代的醇衍生物、其立体异构体或者药学上可接受的盐,及其在医药上的应用。
Drugs covered by this patent
- Xcopri (CENOBAMATE) · Sk Life
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.